LTR

  • 阻害剤の選択性比較
  • 溶解度
カタログ番号 製品カタログ 溶解度(25°C)
DMSO アルコール
S1633 Zafirlukast <1 mg/mL 100 mg/mL <1 mg/mL
S4211 Montelukast Sodium 100 mg/mL 100 mg/mL 100 mg/mL
S8126 MK571 <1 mg/mL 100 mg/mL 19 mg/mL
S5783 Montelukast <1 mg/mL 100 mg/mL 10 mg/mL

LTR製品

新LTR製品
製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S1633

Zafirlukast

Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.

S4211

Montelukast Sodium

Montelukast selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

S8126

MK571

MK-571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.

S5783

Montelukast

Montelukast is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S1633

Zafirlukast

Zafirlukast is an oral leukotriene receptor antagonist (LTRA), used to prevent asthma symptoms.

S4211

Montelukast Sodium

Montelukast selectively antagonizes leukotriene D 4 (LTD4) by binding to it so that block the action of leukotriene D4 on the cysteinyl leukotriene receptor CysLT1.

S8126

MK571

MK-571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) antagonist.

2017, 52:65-71

2018, 129:388-399

2017, 106:313-327

S5783

Montelukast

Montelukast is a leukotriene receptor antagonist used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies.